Search references for MIS416. Phrases containing MIS416
See searches and references containing MIS416!MIS416
Experimental drug
MIS416 is an experimental drug developed by Innate Immunotherapeutics which underwent clinical trials to treat secondary progressive multiple sclerosis
MIS416
sclerosis drug, MIS416. In April 2009 the firm changed its name to Innate Immunotherapeutics to reflect their focus on the development of MIS416, and moved
Innate_Immunotherapeutics
MIS416
MIS416
MIS416
MIS416
MIS416
MIS416
MIS416
MIS416
MIS416